Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 19/20 | 0.78 |
| ▸ | CASP3 | P42574 | 1/20 | 0.78 |
| ▸ | CASP6 | P55212 | 1/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.72 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.72 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.72 |
| ▸ | TSHR | P16473 | 3/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.72 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.72 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.72 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.72 |
| ▸ | HTR2A | P28223 | 1/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.72 |
| ▸ | MC4R | P32245 | 1/20 | 0.72 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2455273 | 1.00 | ADRB2 (0.78) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL7154315 | 0.92 | ADRB2 (0.68) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL7154320 | 0.92 | ADRB2 (0.68) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL8986831 | 0.89 | ADRB2 (0.68) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL11807907 | 0.89 | ADRB2 (0.74) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL7149089 | 0.89 | ADRB2 (0.74) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL7149088 | 0.89 | ADRB2 (0.74) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL11810215 | 0.87 | ADRB2 (0.73) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL8850480 | 0.86 | ADRB2 (0.80) | ADRB2CASP3CASP6MAPK1CYP3A4 | |
| SCHEMBL18326512 | 0.86 | ADRB2 (0.77) | ADRB2CASP3CASP6MAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115658898-A | Chinese and English book entity relation extraction method, system and equipment | 武汉大学 | 2023-01-31 | — | — | CN | claimed |
| US-20260078203-A1 | Carboxyalkyl Chitosan | KIOMED PHARMA (BE) | 2026-03-19 | — | — | US | disclosed |
| US-12503556-B2 | Silicone-acrylate polymers, copolymers, and related methods and compositions | DOW SILICONES CORPORATION (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250382224-A1 | SYSTEM AND METHOD FOR CROSSLINKING A CONTINUOUS MAT OF MINERAL AND/OR PLANT FIBERS | SAINT-GOBAIN ISOVER (FR) | 2025-12-18 | — | — | US | disclosed |
| US-20250375940-A1 | SYSTEM AND METHOD FOR MANUFACTURING A CONTINUOUS MAT OF MINERAL AND/OR PLANT FIBERS | SAINT GOBAIN ISOVER (FR) | 2025-12-11 | — | — | US | disclosed |
| EP-4540447-B1 | SYSTEM AND METHOD FOR CROSSLINKING A CONTINUOUS MAT OF MINERAL AND/OR VEGETABLE FIBERS | SAINT GOBAIN ISOVER (FR) | 2025-11-26 | — | — | EP | disclosed |
| US-12404293-B2 | Method for producing glycan, building block for gylican synthesis, and compound | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-120060915-A | Oxygen evolution reaction electrocatalyst and preparation method and application thereof | 南通海星电子股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| EP-4540448-A1 | SYSTEM AND METHOD FOR MANUFACTURING A CONTINUOUS MAT OF MINERAL AND/OR VEGETABLE FIBERS | Saint-Gobain Isover (FR) | 2025-04-23 | — | — | EP | disclosed |
| EP-4540447-A1 | SYSTEM AND METHOD FOR CROSSLINKING A CONTINUOUS MAT OF MINERAL AND/OR VEGETABLE FIBERS | Saint-Gobain Isover (FR) | 2025-04-23 | — | — | EP | disclosed |
| CN-115151583-B | Silicone-acrylate copolymers and related methods and compositions | 美国陶氏有机硅公司 | 2024-08-02 | — | — | CN | disclosed |
| EP-3891162-B1 | NOVEL DERIVATIVES OF N-3\"-GUANIDINO-2,5-DIDEOXY-5-FLUORO-4,6-DISUBSTITUTED-STREPTAMINE AMINOGLYCOSIDE ANTIBIOTICS | AGILEBIOTICS B V (NL) | 2024-03-06 | — | — | EP | disclosed |
| CN-117310146-A | Anti-freezing antioxidant protective agent and preparation method thereof | 大连医科大学 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023247499-A1 | SYSTEM AND METHOD FOR MANUFACTURING A CONTINUOUS MAT OF MINERAL AND/OR VEGETABLE FIBERS | SAINT-GOBAIN ISOVER (FR) | 2023-12-28 | — | — | WO | disclosed |
| US-11807741-B2 | Articles formed with renewable green plastic materials and starch-based polymeric materials lending increased biodegradability | BiologiQ, Inc. (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230143273-A1 | METHOD FOR PRODUCING GLYCAN, BUILDING BLOCK FOR GYLICAN SYNTHESIS, AND COMPOUND | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230093828-A1 | SILICONE-ACRYLATE POLYMERS, COPOLYMERS, AND RELATED METHODS AND COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC | 2023-03-30 | — | — | US | disclosed |
| CN-115658898-A | Chinese and English book entity relation extraction method, system and equipment | 武汉大学 | 2023-01-31 | — | — | CN | disclosed |
| CN-115151583-A | Silicone-acrylate copolymers and related methods and compositions | 美国陶氏有机硅公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-113593649-B | Method for identifying natural antigen peptide extracted from tissues by using HLA-I candidate peptide library | 中国人民解放军陆军军医大学第一附属医院 | 2022-09-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078203-A1 | Carboxyalkyl Chitosan | CSGALNACT1, CHIT1, ALG1 | ADRB2 4193/4885CASP3 2355/4885CASP6 3092/4885 |
| US-12404293-B2 | Method for producing glycan, building block for gylican synthesis, and compound | OSTC, GYPA, AGL | ADRB2 3006/4885CASP3 4218/4885CASP6 4134/4885 |
| US-20230143273-A1 | METHOD FOR PRODUCING GLYCAN, BUILDING BLOCK FOR GYLICAN SYNTHESIS, AND COMPOUND | OSTC, GYPA, AGL | ADRB2 3006/4885CASP3 4218/4885CASP6 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.